Vantage Hemp Co. Announces Commercial Launch of CBG Isolate and Significant Regulatory Developments
U.S. producer expands its pharmaceutical-grade product portfolio and shares progress with Brazilian Health Regulatory AgencyGreeley, Colorado, November 12, 2024 – Vantage Hemp Co., a globally accredited cannabinoid extractor and manufacturer, announces the commercial launch of its pharmaceutical-grade CBG (cannabigerol) isolate....